S Jalkanen

1.3k total citations
16 papers, 1.0k citations indexed

About

S Jalkanen is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, S Jalkanen has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in S Jalkanen's work include Glycosylation and Glycoproteins Research (7 papers), Cell Adhesion Molecules Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). S Jalkanen is often cited by papers focused on Glycosylation and Glycoproteins Research (7 papers), Cell Adhesion Molecules Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). S Jalkanen collaborates with scholars based in Finland, United States and Portugal. S Jalkanen's co-authors include Markku Jalkanen, Marko Salmi, David P. Andrew, Eugene C. Butcher, Heikki Joensuu, P. Klemi, Stefan G. Hübscher, David Adams, Gillian McNab and Kaisa Granfors and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Cell Biology and Blood.

In The Last Decade

S Jalkanen

16 papers receiving 990 citations

Peers

S Jalkanen

IMMUN

ONCOL

G Conforti Italy

J. Bamat Switzerland

Taneli Tani Finland

Takaaki Hato Japan

Robert M. J. Keehnen Netherlands

David Zhou United States

Pascale Jackers Belgium

G N van Muijen Netherlands

Diane R. Leone United States

Rosemarie Dalchau United Kingdom

G Conforti Italy

S Jalkanen

337 ×0.7

183 ×0.4

550 ×1.6

157 ×0.6

IMMUN

116 ×0.8

ONCOL

Citations per year, relative to S Jalkanen S Jalkanen (= 1×) peers G Conforti

Countries citing papers authored by S Jalkanen

Since Specialization

Citations

This map shows the geographic impact of S Jalkanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Jalkanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Jalkanen more than expected).

Fields of papers citing papers by S Jalkanen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Jalkanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Jalkanen. The network helps show where S Jalkanen may publish in the future.

Co-authorship network of co-authors of S Jalkanen

This figure shows the co-authorship network connecting the top 25 collaborators of S Jalkanen. A scholar is included among the top collaborators of S Jalkanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Jalkanen. S Jalkanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Bono, Petri, Maija Hollmén, Panu Jaakkola, et al.. (2019). Immune activation with a novel immune switch anti-macrophage antibody (anti-Clever-1 mAb; FP-1305) in phase I/II first-in-human MATINS trial in patients with advanced solid tumours. Annals of Oncology. 30. v865–v866. 5 indexed citations

Mustjoki, Satu, Kaisa Auvinen, Anna Kreutzman, et al.. (2012). Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy. Leukemia. 27(4). 914–924. 70 indexed citations

Bono, Petri, et al.. (2001). Distinct ligand binding properties of Mac-2-binding protein and mousephilin C-associated protein. European Journal of Immunology. 31(10). 3075–3084. 4 indexed citations

Jaakkola, Kimmo, et al.. (1998). Labelling lymphocytes with technetium99m-hexamethyl propyleneamine oxime for scintigraphy: an improved labelling procedure. Journal of Immunological Methods. 214(1-2). 187–197. 9 indexed citations

Ristamäki, Raija, et al.. (1998). Clinical significance of circulating CD44 in non-Hodgkin's lymphoma. International Journal of Cancer. 79(3). 221–225. 8 indexed citations

Kirveskari, Juha, et al.. (1998). Increased synovial endothelium binding and transendothelial migration of mononuclear cells duringSalmonella infection. Arthritis & Rheumatism. 41(6). 1054–1063. 26 indexed citations

Ristamäki, Raija, et al.. (1997). Origin and function of circulating CD44 in non-Hodgkin's lymphoma. The Journal of Immunology. 158(6). 3000–3008. 20 indexed citations

Soukka, Tero, Marko Salmi, Lari Häkkinen, et al.. (1997). Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells.. PubMed. 57(11). 2281–9. 61 indexed citations

Salmi, Marko & S Jalkanen. (1996). Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells.. The Journal of Experimental Medicine. 183(2). 569–579. 90 indexed citations

10.

McNab, Gillian, et al.. (1996). Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium. Gastroenterology. 110(2). 522–528. 91 indexed citations

11.

Wuorela, Maarit, S Jalkanen, Paavo Toivanen, & Kaisa Granfors. (1996). Expression of MHC Class II Molecules on Human Monocytes is Regulated Independently from Each Other after Phagocytosis of Bacteria. Scandinavian Journal of Immunology. 43(1). 39–46. 6 indexed citations

12.

Andrew, David P., et al.. (1995). Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms.. The Journal of Experimental Medicine. 181(1). 137–149. 121 indexed citations

13.

Jalkanen, S & Markku Jalkanen. (1992). Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.. The Journal of Cell Biology. 116(3). 817–825. 450 indexed citations

14.

Jalkanen, S. (1991). Lymphocyte traffic to mucosa-associated lymphatic tissues. Immunologic Research. 10(3-4). 268–270. 4 indexed citations

15.

Jalkanen, S, Heikki Joensuu, & P. Klemi. (1990). Prognostic value of lymphocyte homing receptor and S phase fraction in non-Hodgkin's lymphoma. Blood. 75(7). 1549–1556. 52 indexed citations

16.

Jalkanen, S, Heikki Joensuu, & P. Klemi. (1990). Prognostic value of lymphocyte homing receptor and S phase fraction in non-Hodgkin's lymphoma. Blood. 75(7). 1549–1556. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact